FDA Import Refusal 799-1721259-7/21/1 — Eli Lilly & Company
The FDA refused shipment 799-1721259-7/21/1 from Eli Lilly & Company (United States) on Jun 10, 2019. The refused product falls under Drugs and Biologics — INSULIN HUMAN/INSULIN SUSP ISOPHANE HUMA (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jun 10, 2019
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY35 INSULIN HUMAN/INSULIN SUSP ISOPHANE HUMA (ANTI-DIABETIC)
- Charges
- 75